FDA authorized Quest Diagnostics lab method designed to increase COVID-19 molecular diagnostics capacity
On Jul. 29, 2020, Quest Diagnostics announced that the U.S. Food and Drug Administration (FDA) has granted emergency use…
-
-
BARDA procured Regeneron’s REGN-EB3 investigational Ebola treatment for national preparedness
On Jul. 29, 2020, Regeneron announced that the Biomedical Advanced Research and Development Authority (BARDA) had entered into…
-
Sanofi and GSK agreed with the UK government to supply up to 60 million doses of COVID-19 vaccine
On Jul. 29, 2020, Sanofi and GSK announced an agreement with the UK government for the supply of…
-
Intravacc and Celonic to develop and produce a novel COVID-19 vaccine
On Jul. 29, 2020, Intravacc and Celonic Group, a biopharmaceutical contract development and manufacturing organization (CDMO), announced that…
-
PharmaCyte Biotech received CE Mark for licensed COVID-19 molecular tests
On Jul. 29, 2020, PharmaCyte Biotech announced that the COVID-19 Molecular tests it has licensed from Hai Kang…
-
Veracyte and MAVIDx announcd agreement for MAVIDx to develop ultra-high volume COVID-19 testing on the nCounter System
On Jul. 29, 2020, Veracyte and MAVIDx announced an agreement for MAVIDx to develop ultra-high throughput genomic testing…
-
Constant Therapeutics announced start of phase 2 trial of peptide drug TXA127 for COVID-19
On Jul. 29, 2020, Constant Therapeutics announced that its peptide drug TXA127, a pharmaceutical formulation of the natural…
-
Roche updated phase III COVACTA trial of Actemra/RoActemra in hospitalised patients with severe COVID-19 associated pneumonia
On Jul. 28, 2020, Roche announced that the phase III COVACTA study of Actemra®/RoActemra® (tocilizumab) did not meet…
-
Soligenix announced publication of positive pre-clinical results for a novel COVID-19 vaccine
On Jul. 28, 2020, Soligenix announced publication of pre-clinical immunogenicity studies for its CiVax™ program (heat stable COVID-19…
-
US DFC announced $765 million loan to Eastman Kodak to support new expansion into pharmaceuticals
On Jul. 28, 2020, the U.S. International Development Finance Corp. (DFC) announced that it had signed a letter…
-
Experimental COVID-19 vaccine protected upper and lower airways in nonhuman primates
On Jul. 28, 2020, scientists at the National Institute of Allergy and Infectious Diseases reported that two doses…
-
Apogenix started European clinical phase II trial with Asunercept in COVID-19 patients
On Jul. 28, 2020, Apogenix announced that it had received regulatory approval to start a clinical phase II…
-
Gilead Sciences and Satcher Health Leadership Institute partnered to study racial health inequities associated with COVID-19
On Jul. 28, 2020, Gilead Sciences and the Satcher Health Leadership Institute at Morehouse School of Medicine announced…
-
StartX Med Alliance of Remote and Telehealth companies respond to shift in patient care during COVID-19 crisis
On Jul. 28, 2020, StartX announced the launch of its StartX Med Alliance of Remote and Telehealth (SMART)…
-
Amyris and the Infectious Disease Research Institute partnered to advance novel RNA vaccine platform beginning with COVID-19 application
On Jul. 27, 2020, Amyris and the Infectious Disease Research Institute (IDRI) announced the signing of a Collaboration…
-
Emergent BioSolutions signed agreement with AstraZeneca to expand manufacturing for COVID-19 Vaccine candidate
On Jul. 27, 2020, Emergent BioSolutions announced that it had signed an agreement to provide contract development and…
-
Moderna announced phase 3 COVE study of mRNA vaccine against COVID-19 (mRNA-1273) began
On Jul. 27, 2020, Moderna announced that the Phase 3 study of its mRNA vaccine candidate (mRNA-1273) against…
-
Todos Medical announced SARS-nCoV-19 testing kit contract with NJ-based best supply clinical laboratory
On Jul. 27, 2020, Todos Medical announced the Company has entered into a contract to supply NJ-based laboratory…
-
Immunic announced first patients enrolled in investigator-sponsored phase 2 clinical trial of IMU-838 in combination with Oseltamivir for treatment of patients with COVID-19
On Jul. 27, 2020, Immunic announced enrollment of the first patients in an investigator-sponsored phase 2 clinical trial…
-
Onconova Therapeutics submitted application for rigosertib to participate in federally funded human studies in COVID-19 disease
On Jul. 27, 2020, Onconova Therapeutics announced that it had submitted an application with the National Institute of…
-
Texas A&M College Station Bio-Manufacturing Center to produce COVID-19 vaccines
On Jul. 27, 2020, FUJIFILM Diosynth Biotechnologies (FDB) and Texas A&M announced they mass will produce vaccines as…
-
Immune system variation can predict severe COVID-19 outcomes
On Jul. 27, 2020, Yale university researchers reported that differing immune system responses of patients with COVID-19 can…
-
Phase 3 clinical trial of investigational vaccine for COVID-19 began
On Jul. 27, 2020, the National Institutes of Health (NIH) announced that a phase 3 clinical trial designed…
-
Serum Institute conducted phase III clinical trial of BCG vaccine
On Jul. 27, 2020, the Serum Institute of India announced that it was is conducting phase III clinical…
-
Moderna announced expansion of BARDA agreement to support larger phase 3 program for vaccine (mRNA-1273) against COVID-19
On Jul. 26, 2020, Moderna announced a modification to its contract with the Biomedical Advanced Research and Development…
-
LabCorp received authorization for COVID-19 sample pooling
On Jul. 25, 2020, LabCorp announced it received an Emergency Use Authorization from the FDA permitting diagnostic testing…
-
Biotechnology | Clinical Research | COVID-19 | Diagnostics | Infectious Disease | Non-Profit Research | Therapeutics | Vaccine
CIRM board approved two new discovery research projects for COVID-19
On Jul. 24, 2020, the governing Board of the California Institute for Regenerative Medicine (CIRM) approved two new…
-
Biotechnology | COVID-19 | FDA | Infectious Disease | NIH | Vaccine
Dynavax and Medigen announced collaboration to develop a novel adjuvanted COVID-19 vaccine candidate
On Jul. 23, 2020, Dynavax Technologies and Medigen Vaccine Biologics announced their collaboration to develop an adjuvanted vaccine…
-
Novavax and FUJIFILM Diosynth Biotechnologies initiated large scale manufacturing of COVID-19 vaccine candidate
On Jul. 23, 2020, Novavax and FUJIFILM Diosynth Biotechnologies announced an agreement to manufacture bulk drug substance for…
-
AXIM Biotechnologies released Rapid NeuCovix test results showing strong agreement with COVID-19-based neutralization tests
On Jul. 23, 2020, AXIM Biotechnologies announced the completion of a study highlighting the performance of NeuCovix™, AXIM’s…
